JP2022507282A5 - - Google Patents
Info
- Publication number
- JP2022507282A5 JP2022507282A5 JP2021525771A JP2021525771A JP2022507282A5 JP 2022507282 A5 JP2022507282 A5 JP 2022507282A5 JP 2021525771 A JP2021525771 A JP 2021525771A JP 2021525771 A JP2021525771 A JP 2021525771A JP 2022507282 A5 JP2022507282 A5 JP 2022507282A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid according
- strand
- seq
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2018/081106 WO2019092283A1 (en) | 2017-11-13 | 2018-11-13 | Nucleic acids for inhibiting expression of lpa in a cell |
| EPPCT/EP2018/081106 | 2018-11-13 | ||
| EP19174466.3 | 2019-05-14 | ||
| EP19174466 | 2019-05-14 | ||
| PCT/EP2019/081158 WO2020099476A1 (en) | 2018-11-13 | 2019-11-13 | Nucleic acids for inhibiting expression of lpa in a cell |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507282A JP2022507282A (ja) | 2022-01-18 |
| JP2022507282A5 true JP2022507282A5 (enExample) | 2022-08-25 |
| JP7245328B2 JP7245328B2 (ja) | 2023-03-23 |
Family
ID=66554180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525771A Active JP7245328B2 (ja) | 2018-11-13 | 2019-11-13 | 細胞におけるｌｐａの発現を抑制するための核酸 |
Country Status (31)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3607069T3 (da) * | 2017-04-05 | 2022-11-21 | Silence Therapeutics Gmbh | Produkter og sammensætninger |
| HRP20230127T1 (hr) | 2017-11-13 | 2023-03-31 | Silence Therapeutics Gmbh | Nukleinske kiseline za inhibiranje ekspresije lpa u stanici |
| PH12021550801B1 (en) | 2018-11-13 | 2024-04-26 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of lpa in a cell |
| WO2022079221A1 (en) | 2020-10-16 | 2022-04-21 | Sanofi | Rna compositions and methods for inhibiting lipoprotein(a) |
| WO2023041508A2 (en) * | 2021-09-14 | 2023-03-23 | Argonaute RNA Limited | Treatment of cardiovascular disease |
| IL312811A (en) | 2021-11-16 | 2024-07-01 | Shanghai Argo Biopharmaceutical Co Ltd | Composition and method for inhibiting angiotensinogen (agt) protein expression |
| TW202345865A (zh) * | 2022-01-24 | 2023-12-01 | 大陸商上海舶望製藥有限公司 | 抑制LPA(Apo(a))蛋白表達的組合物和方法 |
| KR20240147992A (ko) | 2022-02-09 | 2024-10-10 | 사일런스 테라퓨틱스 게엠베하 | Lpa 발현의 치료적 억제 |
| CN114703184B (zh) * | 2022-03-11 | 2024-06-18 | 厦门甘宝利生物医药有限公司 | Lpa抑制剂及其用途 |
| WO2024013334A1 (en) * | 2022-07-15 | 2024-01-18 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of agt in a cell |
| CN115851723B (zh) * | 2022-10-24 | 2023-10-03 | 厦门甘宝利生物医药有限公司 | 一种抑制lpa基因表达的rna抑制剂及其应用 |
| WO2024151937A1 (en) * | 2023-01-13 | 2024-07-18 | Eli Lilly And Company | Therapeutic oligonucleotide-containing pharmaceutical compositions and dosing regimens using the same |
| CN119585432B (zh) * | 2023-08-22 | 2025-08-12 | 成都先衍生物技术有限公司 | 一种靶向AGT基因表达的siRNA及其缀合物和用途 |
| WO2025064821A2 (en) | 2023-09-21 | 2025-03-27 | Ionis Pharmaceuticals, Inc. | Compounds and methods for inhibiting lpa |
| WO2026046153A1 (zh) * | 2024-08-26 | 2026-03-05 | 倍臻生物技术（苏州）有限公司 | 修饰的双链核糖核酸及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9201440A (nl) | 1992-08-11 | 1994-03-01 | Univ Leiden | Triantennaire clusterglycosiden, hun bereiding en toepassing. |
| US7259150B2 (en) * | 2001-08-07 | 2007-08-21 | Isis Pharmaceuticals, Inc. | Modulation of apolipoprotein (a) expression |
| US7227014B2 (en) | 2001-08-07 | 2007-06-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein (a) expression |
| US20060160759A1 (en) | 2002-09-28 | 2006-07-20 | Jianzhu Chen | Influenza therapeutic |
| CN101278059A (zh) * | 2005-07-28 | 2008-10-01 | 肿瘤疗法科学股份有限公司 | 诊断和治疗肾细胞癌的方法 |
| WO2009151644A2 (en) | 2008-06-13 | 2009-12-17 | Yale University | Small molecule inhibitors of autotaxin methods of use |
| EP2490699A1 (en) * | 2009-10-20 | 2012-08-29 | Santaris Pharma A/S | Oral delivery of therapeutically effective lna oligonucleotides |
| EP3564374A1 (en) * | 2013-06-21 | 2019-11-06 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
| WO2016149020A1 (en) * | 2015-03-17 | 2016-09-22 | Arrowhead Research Corporation | Rna interference agents |
| JOP20160211B1 (ar) * | 2015-10-01 | 2021-08-17 | Arrowhead Pharmaceuticals Inc | تراكيب وأساليب لتثبيط تعبير جيني للـ lpa |
| EP3228326A1 (en) | 2016-04-05 | 2017-10-11 | Silence Therapeutics GmbH | Nucleic acid linked to a trivalent glycoconjugate |
| DK3607069T3 (da) | 2017-04-05 | 2022-11-21 | Silence Therapeutics Gmbh | Produkter og sammensætninger |
| HRP20230127T1 (hr) * | 2017-11-13 | 2023-03-31 | Silence Therapeutics Gmbh | Nukleinske kiseline za inhibiranje ekspresije lpa u stanici |
| EP3735461A1 (en) * | 2017-11-13 | 2020-11-11 | Silence Therapeutics GmbH | Nucleic acids for inhibiting expression of aldh2 in a cell |
| PH12021550801B1 (en) | 2018-11-13 | 2024-04-26 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of lpa in a cell |
-
2019
- 2019-11-13 PH PH1/2021/550801A patent/PH12021550801B1/en unknown
- 2019-11-13 BR BR112021009213-7A patent/BR112021009213A2/pt active IP Right Grant
- 2019-11-13 PL PL19801033.2T patent/PL3880818T3/pl unknown
- 2019-11-13 SG SG11202103882QA patent/SG11202103882QA/en unknown
- 2019-11-13 HU HUE19801033A patent/HUE060703T2/hu unknown
- 2019-11-13 EP EP19801033.2A patent/EP3880818B1/en active Active
- 2019-11-13 CA CA3119239A patent/CA3119239C/en active Active
- 2019-11-13 AU AU2019380628A patent/AU2019380628B2/en active Active
- 2019-11-13 ES ES19801033T patent/ES2932295T3/es active Active
- 2019-11-13 HR HRP20221358TT patent/HRP20221358T1/hr unknown
- 2019-11-13 EA EA202190895A patent/EA202190895A1/ru unknown
- 2019-11-13 SM SM20230050T patent/SMT202300050T1/it unknown
- 2019-11-13 EP EP22197500.6A patent/EP4219712A3/en not_active Withdrawn
- 2019-11-13 KR KR1020217017471A patent/KR102553386B1/ko active Active
- 2019-11-13 CN CN202510076171.0A patent/CN119842706A/zh active Pending
- 2019-11-13 FI FIEP19801033.2T patent/FI3880818T3/fi active
- 2019-11-13 DK DK19801033.2T patent/DK3880818T3/da active
- 2019-11-13 CR CR20210301A patent/CR20210301A/es unknown
- 2019-11-13 WO PCT/EP2019/081158 patent/WO2020099476A1/en not_active Ceased
- 2019-11-13 MA MA58208A patent/MA58208B1/fr unknown
- 2019-11-13 US US17/293,303 patent/US20220002722A1/en not_active Abandoned
- 2019-11-13 PE PE2021000650A patent/PE20211282A1/es unknown
- 2019-11-13 MX MX2021005590A patent/MX2021005590A/es unknown
- 2019-11-13 PT PT198010332T patent/PT3880818T/pt unknown
- 2019-11-13 LT LTEPPCT/EP2019/081158T patent/LT3880818T/lt unknown
- 2019-11-13 RS RS20221119A patent/RS63778B1/sr unknown
- 2019-11-13 SI SI201930387T patent/SI3880818T1/sl unknown
- 2019-11-13 CN CN201980074785.8A patent/CN113227372A/zh active Pending
- 2019-11-13 JP JP2021525771A patent/JP7245328B2/ja active Active
-
2021
- 2021-05-06 SA SA521421963A patent/SA521421963B1/ar unknown
- 2021-05-10 CL CL2021001225A patent/CL2021001225A1/es unknown
- 2021-05-12 IL IL283159A patent/IL283159B1/en unknown
- 2021-06-04 CO CONC2021/0007372A patent/CO2021007372A2/es unknown
- 2021-12-22 US US17/559,479 patent/US11499153B2/en active Active
-
2025
- 2025-07-08 US US19/263,110 patent/US20260078372A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507282A5 (enExample) | ||
| JP2021502120A5 (enExample) | ||
| TWI823866B (zh) | 用於抑制類血管生成素蛋白-3(ANGPTL3)表現的RNAi藥劑及組合物及使用方法 | |
| CN1139385C (zh) | 用于脂化亲水分子的方法和组合物 | |
| HRP20221358T1 (hr) | Nukleinske kiseline za inhibiranje ekspresije lpa u stanici | |
| CN113636947B (zh) | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 | |
| CN113795582A (zh) | 核酸、药物组合物与缀合物及制备方法和用途 | |
| CN103492568B (zh) | 用于siRNA的半乳糖簇‑药代动力学调节剂靶向部分 | |
| CN1120707C (zh) | 增强生物分子的细胞摄取的配体 | |
| IL274503B2 (en) | Nucleic acids for inhibiting expression of lpa in a cell | |
| JP6784750B2 (ja) | 薬物送達のためのマルチリガンド剤 | |
| JP2024526890A5 (enExample) | ||
| HUE026811T2 (en) | Compositions for targeted delivery of sirna | |
| US20030119724A1 (en) | Ligands to enhance cellular uptake of biomolecules | |
| JP2022501059A5 (enExample) | ||
| JP2007504830A5 (enExample) | ||
| JP2017521045A5 (enExample) | ||
| JPH10501237A (ja) | オリゴヌクレオチドのためのシクロデキストリン細胞送達系 | |
| JP2021533800A5 (enExample) | ||
| CN1118140A (zh) | 为提高在酸性pH的稳定性而改性的低聚核苷酸 | |
| JP2018531245A (ja) | オリゴヌクレオチドコンジュゲーション方法 | |
| JPWO2018003739A1 (ja) | 機能的リガンドを含む核酸複合体 | |
| KR20250002732A (ko) | 중추 신경계 전달용 지질 나노입자 제제 | |
| KR20160147768A (ko) | 올리고뉴클레오타이드 조성물 및 이를 제조하는 방법 | |
| US20240247274A1 (en) | Fatty acid conjugates of nucleic acids |